Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13. (Q46068547)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13. |
scientific article |
Statements
1 reference
Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13. (English)
1 reference
Donna Reece
1 reference
Kevin W Song
1 reference
Tommy Fu
1 reference
Birgitte Roland
1 reference
Hong Chang
1 reference
Douglas E Horsman
1 reference
Adnan Mansoor
1 reference
Christine Chen
1 reference
Esther Masih-Khan
1 reference
Young Trieu
1 reference
Helene Bruyere
1 reference
Douglas A Stewart
1 reference
Nizar J Bahlis
1 reference
30 March 2009
1 reference
1 reference
114
1 reference
3
1 reference
522-525
1 reference
Identifiers
1 reference